Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Kazia Therapeutics (KZIA) EBITDA (2009 - 2011)

Kazia Therapeutics (KZIA) posted EBITDA of -$950387.2 for Q4 2011, up 81.61% on a QoQ basis from -$5.2 million in Q4 2010, and up 81.61% year-over-year from -$523310.2 in Q4 2010.

Kazia Therapeutics (KZIA) has 3 years of EBITDA data on file, last reported at -$950387.2 in Q4 2011.

  • In Q4 2011, EBITDA rose 81.61% year-over-year to -$950387.2; the TTM figure through Dec 2011 stood at -$3.9 million (up 73.18% YoY), while the FY2025 annual figure was -$14.4 million, up 19.35% from the prior year.
  • EBITDA rose to -$950387.2 in Q4 2011, from -$5.2 million in the prior quarter.
  • Across five years, EBITDA topped out at -$950387.2 in Q4 2011 and bottomed at -$5.8 million in Q4 2009.
  • A 3-year average of -$4.0 million and a median of -$5.2 million in 2010 frame the typical range for EBITDA.
  • Annual changes were most pronounced in 2010 — EBITDA increased 11.24% — and 2011, when it jumped 81.61%.
  • Year by year, EBITDA stood at -$5.8 million in 2009, then gained by 11.24% to -$5.2 million in 2010, then jumped by 81.61% to -$950387.2 in 2011.
  • The last three EBITDA figures came in at -$950387.2 (Q4 2011), -$5.2 million (Q4 2010), and -$5.8 million (Q4 2009), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.63 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -19.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -14.44 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.14 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.82 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 661.60 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 201.19 Mn
10 Kazia Therapeutics 1.55 Bn 1.55 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2011 -950,387.22
Dec 31, 2010 -5.17 Mn
Dec 31, 2009 -5.82 Mn